View in EDS PDF Full Text

Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.

Saved in:
Bibliographic Details
Title: Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.
Authors: Farace, F.1,2, Mathiot, C.3,4, Brandely, M.5, Tursz, T.1, Dorval, T.3, Pouillart, P.3, Triebel, F., Hercend, T.1,2, Fridman, W. H.3,4
Source: Clinical & Experimental Immunology. Nov1990, Vol. 82 Issue 2, p194-199. 6p.
Database: Academic Search Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 15987313
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Farace%2C+F%2E%22">Farace, F.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Mathiot%2C+C%2E%22">Mathiot, C.</searchLink><relatesTo>3,4</relatesTo><br /><searchLink fieldCode="AR" term="%22Brandely%2C+M%2E%22">Brandely, M.</searchLink><relatesTo>5</relatesTo><br /><searchLink fieldCode="AR" term="%22Tursz%2C+T%2E%22">Tursz, T.</searchLink><relatesTo>1</relatesTo><br /><searchLink fieldCode="AR" term="%22Dorval%2C+T%2E%22">Dorval, T.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Pouillart%2C+P%2E%22">Pouillart, P.</searchLink><relatesTo>3</relatesTo><br /><searchLink fieldCode="AR" term="%22Triebel%2C+F%2E%22">Triebel, F.</searchLink><br /><searchLink fieldCode="AR" term="%22Hercend%2C+T%2E%22">Hercend, T.</searchLink><relatesTo>1,2</relatesTo><br /><searchLink fieldCode="AR" term="%22Fridman%2C+W%2E+H%2E%22">Fridman, W. H.</searchLink><relatesTo>3,4</relatesTo>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+%26+Experimental+Immunology%22">Clinical & Experimental Immunology</searchLink>. Nov1990, Vol. 82 Issue 2, p194-199. 6p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=15987313
RecordInfo BibRecord:
  BibEntity:
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 6
        StartPage: 194
    Titles:
      – TitleFull: Phase I trial with recombinant interleukin-2 (rIL-2): immune activation by rIL-2 alone or following pretreatment with recombinant interferon-gamma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Farace, F.
      – PersonEntity:
          Name:
            NameFull: Mathiot, C.
      – PersonEntity:
          Name:
            NameFull: Brandely, M.
      – PersonEntity:
          Name:
            NameFull: Tursz, T.
      – PersonEntity:
          Name:
            NameFull: Dorval, T.
      – PersonEntity:
          Name:
            NameFull: Pouillart, P.
      – PersonEntity:
          Name:
            NameFull: Triebel, F.
      – PersonEntity:
          Name:
            NameFull: Hercend, T.
      – PersonEntity:
          Name:
            NameFull: Fridman, W. H.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 11
              Text: Nov1990
              Type: published
              Y: 1990
          Identifiers:
            – Type: issn-print
              Value: 00099104
          Numbering:
            – Type: volume
              Value: 82
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical & Experimental Immunology
              Type: main
ResultId 1